Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data.
Giovinazzo F, Soggiu F, Jang JY, Versteijne E, van Tienhoven G, van Eijck CH, Han Y, Choi SH, Kang CM, Zalupski M, Ahmad H, Yentz S, Helton S, Rose JB, Takishita C, Nagakawa Y, Abu Hilal M.
Giovinazzo F, et al.
Front Oncol. 2020 Aug 11;10:1112. doi: 10.3389/fonc.2020.01112. eCollection 2020.
Front Oncol. 2020.
PMID: 32850319
Free PMC article.